The TGF-beta superfamily member activin A in pulmonary arterial hypertension. Clinical and experimental studies

被引:0
|
作者
Yndestad, A.
Larsen, K. O.
Oie, E.
Ueland, T.
Anfinsen, O. G.
Christensen, G.
Aukrust, P.
Andreassen, A. K.
机构
[1] Univ Oslo, Rikshosp, Internal Med Res Inst, N-0027 Oslo, Norway
[2] Univ Oslo, Ulleval Hosp, Expt Med Res Inst, Oslo, Norway
[3] Univ Oslo, Rikshosp, Inst Surg Res, N-0027 Oslo, Norway
[4] Univ Oslo, Rikshosp, Dept Cardiol, N-0027 Oslo, Norway
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
P611
引用
收藏
页码:83 / 83
页数:1
相关论文
共 50 条
  • [31] INFLUENCE OF AGE ON CLINICAL PHENOTYPES OF INCIDENT IDIOPATHIC PULMONARY ARTERIAL HYPERTENSION. RESULTS FROM THE PULMONARY HYPERTENSION REGISTRY OF THE UK AND IRELAND
    Ling, Y.
    Johnson, M. K.
    Kiely, D.
    Condliffe, R.
    Elliot, C.
    Gibbs, S.
    Howard, L.
    Pepke-Zaba, J.
    Sheares, K.
    Corris, P.
    Fisher, A.
    Lordan, J.
    Gaine, S.
    Coghlan, G.
    Wort, J.
    Gatzoulis, M.
    Peacock, A. J.
    THORAX, 2011, 66 : A34 - A35
  • [32] ACTRIIA-Fc Rebalances BMP and Activin/TGF-β Signaling to Attenuate Experimental Pulmonary Hypertension
    Yung, L.
    Yang, P.
    Bocobo, G.
    Dinter, T.
    Pearsall, S.
    Sako, D.
    Kumar, R.
    Yu, P. B.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
  • [33] MicroRNAs and PARP: co-conspirators with ROS in pulmonary hypertension. Focus on "miR-223 reverses experimental pulmonary arterial hypertension"
    Smith, Kimberly A.
    Yuan, Jason X. -J.
    Schumacker, Paul T.
    AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 2015, 309 (06): : C361 - C362
  • [34] Publisher Correction: Stable isotope metabolomics of pulmonary artery smooth muscle and endothelial cells in pulmonary hypertension and with TGF-beta treatment
    Daniel Hernandez-Saavedra
    Linda Sanders
    Scott Freeman
    Julie A. Reisz
    Michael H. Lee
    Claudia Mickael
    Rahul Kumar
    Biruk Kassa
    Sue Gu
    Angelo D’ Alessandro
    Kurt R. Stenmark
    Rubin M. Tuder
    Brian B. Graham
    Scientific Reports, 10
  • [35] Endothelin antagonists in pulmonary hypertension: Clinical and experimental studies
    Adnot, S
    BRITISH JOURNAL OF PHARMACOLOGY, 1997, 122 : U154 - U154
  • [36] Consequences of Alteration in TGF-β/ALK1/endoglin Signaling in the Pathogenesis of Human and Rodent Pulmonary Arterial Hypertension.
    Gore, B.
    Dewachter, L.
    Tu, L.
    Fadel, E.
    Humbert, M.
    Lebrin, F.
    Guignabert, C.
    Eddahibi, S.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2010, 181
  • [37] Increased Degradation of BMPR2 in a TGFβ Dependent Transgenic Mouse Model of Scleroderma with Susceptibility to Pulmonary Arterial Hypertension.
    Gilbane, Adrian J.
    Derrett-Smith, Emma C.
    Pearce, Andrew
    Denton, Christopher P.
    Holmes, Alan M.
    ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S332 - S332
  • [38] Over, and Underexpression of Endothelin 1 and TGF-Beta Family Ligands and Receptors in Lung Tissue of Broilers with Pulmonary Hypertension
    Dominguez-Avila, Norma
    Ruiz-Castaneda, Gabriel
    Gonzalez-Ramirez, Javier
    Fernandez-Jaramillo, Nora
    Escoto, Jorge
    Sanchez-Munoz, Fausto
    Marquez-Velasco, Ricardo
    Bojalil, Rafael
    Espinosa-Cervantes, Roman
    Sanchez, Fausto
    BIOMED RESEARCH INTERNATIONAL, 2013, 2013
  • [39] TGF-beta mRNA expression in the renal pelvis after experimental and clinical ureteropelvic junction obstruction
    Seremetis, GM
    Maizels, M
    JOURNAL OF UROLOGY, 1996, 156 (01): : 261 - 266
  • [40] REGULATION OF OP-1 MESSENGER-RNA EXPRESSION IN-VIVO - STRUCTURE OF OP-3, A NEW MEMBER OF THE TGF-BETA SUPERFAMILY
    OZKAYNAK, E
    JIN, DF
    DORAI, H
    CLIFFORD, GM
    MAGADA, D
    OPPERMANN, H
    JOURNAL OF BONE AND MINERAL RESEARCH, 1993, 8 : S377 - S377